{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:38:45Z","timestamp":1788514725673,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre","doi-asserted-by":"publisher","award":["UMO-2015\/19\/B\/NZ5\/00096"],"award-info":[{"award-number":["UMO-2015\/19\/B\/NZ5\/00096"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jagiellonian University Medical College, Cracow, Poland","award":["K\/ZDS\/006162"],"award-info":[{"award-number":["K\/ZDS\/006162"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.rmed.2019.04.021","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T12:12:22Z","timestamp":1556626342000},"page":"51-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease"],"prefix":"10.1016","volume":"152","author":[{"given":"Katarzyna Ewa","family":"Tyrak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Kupry\u015b-Lipi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Czarnobilska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Jakie\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Pajdzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"\u0106miel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Plutecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Koziej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Gawro\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Konduracka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Kuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7635-8103","authenticated-orcid":false,"given":"Marek","family":"Sanak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8994-0036","authenticated-orcid":false,"given":"Lucyna","family":"Mastalerz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2019.04.021_bib1","article-title":"Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)- a EAACI position paper","author":"Kowalski","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2019.04.021_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4168\/aair.2015.7.4.312","article-title":"Seven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice?","volume":"7","author":"Kowalski","year":"2015","journal-title":"Allergy Asthma Immunol. Res."},{"key":"10.1016\/j.rmed.2019.04.021_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/MCP.0000000000000530","article-title":"Heterogeneity of NSAID-Exacerbated Respiratory Disease: has the time come for subphenotyping?","volume":"25","author":"Kowalski","year":"2019","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.rmed.2019.04.021_bib4","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaci.2009.12.977","article-title":"Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers","volume":"125","author":"Higashi","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib5","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/all.12512","article-title":"Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity","volume":"69","author":"Mastalerz","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2019.04.021_bib6","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2005.02.029","article-title":"Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis","volume":"115","author":"P\u00e9rez-Novo","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib7","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","article-title":"Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes","volume":"119","author":"Laidlaw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rmed.2019.04.021_bib8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jaci.2018.06.001","article-title":"A trial of P2Y12 receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease","volume":"143","author":"Laidlaw","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib9","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jaci.2015.10.020","article-title":"Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease","volume":"137","author":"Buchheit","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2500\/ajra.2018.32.4498","article-title":"Role of group 2 innate lymphocytes in aspirin-exacerbated respiratory disease pathogenesis","volume":"32","author":"White","year":"2018","journal-title":"Am. J. Rhinol. Allergy"},{"key":"10.1016\/j.rmed.2019.04.021_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/ACI.0000000000000374","article-title":"Aspirin challenge and desensitization: how, when and why","volume":"17","author":"Cortellini","year":"2017","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/1945892418770260","article-title":"Long-term clinical outcomes of aspirin desensitization with continuous daily aspirin therapy in aspirin-exacerbated respiratory disease","volume":"32","author":"Walters","year":"2018","journal-title":"Am. J. Rhinol. Allergy"},{"key":"10.1016\/j.rmed.2019.04.021_bib13","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/all.12269","article-title":"Aspirin 300 mg\/day is effective for treating aspirin-exacerbated respiratory disease","volume":"68","author":"Comert","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2019.04.021_bib14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1164\/rccm.201403-0562LE","article-title":"Osteopontin and periostin are associated with a 20-year decline of pulmonary function in patients with asthma","volume":"190","author":"Kanemitsu","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.04.021_bib15","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1398-9995.2007.01409.x","article-title":"EAACI\/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity","volume":"62","author":"Nizankowska-Mogilnicka","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2019.04.021_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2006.06.019","article-title":"Selection of patients for aspirin desensitization treatment","volume":"118","author":"Stevenson","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/09031936.02.00000102","article-title":"Standardised methodology of sputum induction and processing","volume":"20","author":"Djukanovic","year":"2002","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2019.04.021_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","article-title":"Inflammatory subtypes in asthma: assessment and identification using induced sputum","volume":"11","author":"Simpson","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2019.04.021_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/thx.2008.102822","article-title":"Occupational rhinitis in workers investigated for occupational asthma","volume":"64","author":"Castano","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2019.04.021_bib20","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jaci.2017.01.022","article-title":"Microparticles in nasal lavage fluids in chronic rhinosinusitis: potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease","volume":"140","author":"Takahashi","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0194-5998(97)70005-6","article-title":"Staging for rhinosinusitis","volume":"117","author":"Lund","year":"1997","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.rmed.2019.04.021_bib22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2014.02.041","article-title":"Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study","volume":"134","author":"\u015awierczy\u0144ska-Kr\u0119pa","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaci.2017.05.006","article-title":"Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: a single-center study","volume":"141","author":"Waldram","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib24","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial","volume":"140","author":"Bachert","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2500\/aap.2016.37.3935","article-title":"Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine","volume":"37","author":"Makowska","year":"2016","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.rmed.2019.04.021_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0091-6749(96)70123-9","article-title":"Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes","volume":"98","author":"Stevenson","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib27","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/alr.21826","article-title":"Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease: an evidence-based review with recommendations","volume":"6","author":"Levy","year":"2016","journal-title":"Int. Forum Allergy Rhinol."},{"key":"10.1016\/j.rmed.2019.04.021_bib28","article-title":"Sinus surgery is associated with a decrease in aspirin-induced reaction severity in patients with aspirin exacerbated respiratory disease","author":"Jerschow","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2019.04.021_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/cyto.2002.1972","article-title":"Analysis of novel disease-related genes in bronchial asthma","volume":"19","author":"Yuyama","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.rmed.2019.04.021_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2006.02.046","article-title":"Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals","volume":"118","author":"Takayama","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib31","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jaci.2010.06.036","article-title":"The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases","volume":"126","author":"Katial","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2016.11.023","article-title":"Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease","volume":"140","author":"Eastman","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib33","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.4049\/jimmunol.1500905","article-title":"Aspirin-exacerbated respiratory disease involves a cysteinyl leukotriene-driven IL-33-mediated mast cell activation pathway","volume":"195","author":"Liu","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12890-016-0230-4","article-title":"Periostin levels and eosinophilic inflammation in poorly-controlled asthma","volume":"16","author":"Simpson","year":"2016","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.rmed.2019.04.021_bib35","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/MLG.0b013e31816b4b6f","article-title":"Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma","volume":"118","author":"Stankovic","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.rmed.2019.04.021_bib36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.anai.2016.06.006","article-title":"Chronic rhinosinusitis phenotypes","volume":"117","author":"Steinke","year":"2016","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D\u2082: a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.04.021_bib38","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(95)90799-8","article-title":"Prostaglandin E2 and aspirin-induced asthma","volume":"345","author":"Szczeklik","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2019.04.021_bib39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4168\/aair.2014.6.4.288","article-title":"Cysteinyl leukotrienes and their receptors; emerging concepts","volume":"6","author":"Kanaoka","year":"2014","journal-title":"Allergy Asthma Immunol. Res."},{"key":"10.1016\/j.rmed.2019.04.021_bib40","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/cea.12654","article-title":"Induced sputum supernatant bioactive lipid mediators can identify subtypes of asthma","volume":"45","author":"Mastalerz","year":"2015","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.rmed.2019.04.021_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rmed.2018.08.009","article-title":"Aspirin desensitization in aspirin-exacerbated respiratory disease: new insights into the molecular mechanisms","volume":"143","author":"Bobolea","year":"2018","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2019.04.021_bib42","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa013508","article-title":"Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis","volume":"347","author":"Sousa","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2019.04.021_bib43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2125.2011.03943.x","article-title":"Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy","volume":"72","author":"Warner","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.rmed.2019.04.021_bib44","doi-asserted-by":"crossref","first-page":"15858","DOI":"10.1073\/pnas.0707413104","article-title":"Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids","volume":"104","author":"Woodruff","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119301490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119301490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:51:30Z","timestamp":1760615490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611119301490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":44,"alternative-id":["S0954611119301490"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2019.04.021","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2019.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}